275 related articles for article (PubMed ID: 28678408)
1. Longitudinal regret after treatment for low- and intermediate-risk prostate cancer.
Hurwitz LM; Cullen J; Kim DJ; Elsamanoudi S; Hudak J; Colston M; Travis J; Kuo HC; Rice KR; Porter CR; Rosner IL
Cancer; 2017 Nov; 123(21):4252-4258. PubMed ID: 28678408
[TBL] [Abstract][Full Text] [Related]
2. Race, Decisional Regret and Prostate Cancer Beliefs: Identifying Targets to Reduce Racial Disparities in Prostate Cancer.
DeWitt-Foy ME; Gam K; Modlin C; Kim SP; Abouassaly R
J Urol; 2021 Feb; 205(2):426-433. PubMed ID: 33226309
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.
Banerji JS; Hurwitz LM; Cullen J; Wolff EM; Levie KE; Rosner IL; Brand TC; LʼEsperance JO; Sterbis JR; Porter CR
Urol Oncol; 2017 May; 35(5):234-242. PubMed ID: 28110975
[TBL] [Abstract][Full Text] [Related]
4. Treatment decisional regret among men with prostate cancer: Racial differences and influential factors in the North Carolina Health Access and Prostate Cancer Treatment Project (HCaP-NC).
Morris BB; Farnan L; Song L; Addington EL; Chen RC; Nielsen ME; Mishel M; Mohler JL; Bensen JT
Cancer; 2015 Jun; 121(12):2029-35. PubMed ID: 25740564
[TBL] [Abstract][Full Text] [Related]
5. Quality of care received and patient-reported regret in prostate cancer: Analysis of a population-based prospective cohort.
Holmes JA; Bensen JT; Mohler JL; Song L; Mishel MH; Chen RC
Cancer; 2017 Jan; 123(1):138-143. PubMed ID: 27622730
[TBL] [Abstract][Full Text] [Related]
6. Decisional regret after robotic-assisted laparoscopic prostatectomy is higher in African American men.
Collingwood SA; McBride RB; Leapman M; Hobbs AR; Kwon YS; Stensland KD; Schwartz RM; Pollard ME; Samadi DB
Urol Oncol; 2014 May; 32(4):419-25. PubMed ID: 24411791
[TBL] [Abstract][Full Text] [Related]
7. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
[TBL] [Abstract][Full Text] [Related]
8. Treatment Decision Regret Among Long-Term Survivors of Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study.
Hoffman RM; Lo M; Clark JA; Albertsen PC; Barry MJ; Goodman M; Penson DF; Stanford JL; Stroup AM; Hamilton AS
J Clin Oncol; 2017 Jul; 35(20):2306-2314. PubMed ID: 28493812
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer.
Nguyen PL; Chen MH; Hoffman KE; Chen RC; Hu JC; Bennett CL; Kattan MW; Sartor O; Stein K; D'Amico AV
BJU Int; 2012 Jul; 110(2):201-5. PubMed ID: 22085233
[TBL] [Abstract][Full Text] [Related]
10. Regret in men treated for localized prostate cancer.
Hu JC; Kwan L; Saigal CS; Litwin MS
J Urol; 2003 Jun; 169(6):2279-83. PubMed ID: 12771770
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life for men with prostate cancer--an evaluation of outcomes 12-24 months after treatment.
Brassell SA; Elsamanoudi SI; Cullen J; Williams ME; McLeod DG
Urol Oncol; 2013 Nov; 31(8):1504-10. PubMed ID: 22608541
[TBL] [Abstract][Full Text] [Related]
12. Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy.
Jeldres C; Cullen J; Hurwitz LM; Wolff EM; Levie KE; Odem-Davis K; Johnston RB; Pham KN; Rosner IL; Brand TC; L'Esperance JO; Sterbis JR; Etzioni R; Porter CR
Cancer; 2015 Jul; 121(14):2465-73. PubMed ID: 25845467
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy.
Lunger L; Meissner VH; Kopp BCG; Dinkel A; Schiele S; Ankerst DP; Gschwend JE; Herkommer K
BMC Urol; 2023 Aug; 23(1):139. PubMed ID: 37612591
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of health-related quality of life outcomes among men treated for intermediate- and high-risk prostate cancer: the impact of primary and secondary therapies.
Alsinnawi M; Cullen J; Hurwitz LM; Levie KE; Burns JF; Rosner IL; Brand TC; Stroup S; Sterbis JR; Rice K; Conti G; Porter CR
Can J Urol; 2019 Aug; 26(4):9809-9820. PubMed ID: 31469635
[TBL] [Abstract][Full Text] [Related]
15. The association between race and treatment regret among men with recurrent prostate cancer.
Mahal BA; Chen MH; Bennett CL; Kattan MW; Sartor O; Stein K; D'Amico AV; Nguyen PL
Prostate Cancer Prostatic Dis; 2015 Mar; 18(1):38-42. PubMed ID: 25348256
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
[TBL] [Abstract][Full Text] [Related]
17. Regret and fear in prostate cancer: The relationship between treatment appraisals and fear of recurrence in prostate cancer survivors.
Maguire R; Hanly P; Drummond FJ; Gavin A; Sharp L
Psychooncology; 2017 Nov; 26(11):1825-1831. PubMed ID: 28124398
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.
Sureda A; Fumadó L; Ferrer M; Garín O; Bonet X; Castells M; Mir MC; Abascal JM; Vigués F; Cecchini L; Suárez JF
Health Qual Life Outcomes; 2019 Jan; 17(1):11. PubMed ID: 30642340
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive quality-of-life outcomes in the setting of a multidisciplinary, equal access prostate cancer clinic.
Rice K; Hudak J; Peay K; Elsamanoudi S; Travis J; Lockhart R; Cullen J; Black L; Houge S; Brassell S
Urology; 2010 Nov; 76(5):1231-8. PubMed ID: 20579698
[TBL] [Abstract][Full Text] [Related]
20. Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.
Shaverdian N; Verruttipong D; Wang PC; Kishan AU; Demanes DJ; McCloskey S; Kupelian P; Steinberg ML; King CR
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):516-525. PubMed ID: 28126301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
